乳腺癌免疫活性细胞反应的意义及淋巴结转移的危险因素分析
被引量:1
出处
《临床与实验病理学杂志》
CAS
CSCD
北大核心
2008年第2期239-241,共3页
Chinese Journal of Clinical and Experimental Pathology
基金
南通市社会发展计划项目(2006-S6848)
参考文献4
-
1Rosenberg S A. Progress in human tumour immunology and immuno therapy[J]. Nature, 2001,411:380 -384.
-
2Tmpani J A. Granzymes: a family of lymphocyte granule srine proteases[J]. Genome Biol, 2001,2(12) :3014.
-
3孙正魁,姚榛祥.乳腺癌免疫逃逸机理的研究进展[J].中国普外基础与临床杂志,2004,11(1):26-28. 被引量:4
-
4熊玲静,梁昌华,邓豪余,李新辉,胡硕,段华新.乳腺癌nm23蛋白表达的相关因素及其骨转移危险因素分析[J].中南大学学报(医学版),2004,29(1):75-78. 被引量:2
二级参考文献30
-
1[1]Meazza R,Gaggero A,Neglia F,et al.Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides [J].Eur J Immunol,1997:27(5):1049
-
2[2]Carosella ED,Rouas-Freiss N,Paul P,et al.HLA-G: a tolerance molecule from the major histocompatibility complex [J].Immunol Today,1999:20(2):60
-
3[3]D'Orazio TJ,Niederkorn JY.A novel role for TGF-beta and IL-10 in the induction of immune privilege [J].J Immunol,1998:160(5):2089
-
4[4]Salazar-Onfray F.Interleukin-10: a cytokine used by tumors to escape immunosurveillance [J].Med Oncol,1999:16(2):86
-
5[5]Chouaib S,Asselin-Paturel C,Mami-Chouaib F,et al.The host-tumor immune conflict: from immunosuppression to resistance and destruction [J].Immunol Today,1997:18(10):493
-
6[6]Matsni S,Ahlers JD,Vortmeyer AO,et al.A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL [J].J Immunol,1999:163(1):184
-
7[7]Adler AJ,Marsh DW,Yochum GS,et al.CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J].J Exp Med,1998:187(10):1555
-
8[8]O'Connell J,Bennett MW,O'Sullivan GC,et al.The Fas counterattack: cancer as a site of immune privilege [J].Immunol Today,1999:20(1):46
-
9[9]Zia A,Schildberg FM,Funke I.MHC class Ⅰ negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in ROMO breast cancer patients [J].Int J Cancer,2001:93(4):566
-
10[10]Feinmesser M,Sulkes A,Morgenstern S,et al.HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities [J].J Clin Pathol,2000:53(4):286
共引文献4
-
1朱东兵,陈莉.乳腺癌C-erbB-2、nm23表达与免疫活性细胞反应的相关性[J].中国肿瘤,2007,16(6):439-441. 被引量:2
-
2刘徽婷,王嘉军.乳腺肿瘤细胞免疫逃逸机制的研究进展[J].微生物学免疫学进展,2010,38(1):79-82. 被引量:3
-
3金宇,张仲海,杨赶梅,甘洁文,张莉,王琦.扶正消瘤颗粒剂对乳腺癌术后放化疗后患者T淋巴细胞亚群的影响[J].深圳中西医结合杂志,2010,20(2):78-80. 被引量:2
-
4马纯华,张丽娟,颜君,唐海林.中文版改良疾病感知问卷的修订及其在乳腺癌患者中的信效度检验[J].中国全科医学,2015,18(27):3328-3334. 被引量:17
同被引文献13
-
1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
-
2张丰,李楠.p27的功能调控及其在乳腺肿瘤治疗中的应用[J].中国肿瘤生物治疗杂志,2006,13(5):397-399. 被引量:4
-
3赵勇,高建飞,饶智国,欧武陵,朱宇泽,杜光祖.胃癌中Cks1、p27^(Kip1)和Skp2蛋白的表达[J].肿瘤防治研究,2007,34(2):118-120. 被引量:7
-
4张宏艳,刘端祺,范萍,黄其敏,侯新燕,彭雁,矫健,吕楠.乳腺癌普查初步报道及资料分析[J].解放军医学杂志,2007,32(6):654-654. 被引量:49
-
5Sitry D,Seeliger MA,Ko TK,et al.Three different binding sites of Cksl are required for p27-ubiquitin ligation[].Journal of Biological Chemistry.2002
-
6Shapira M,Ben-Izhak O,Linn S,et al.The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma[].Cancer.2005
-
7Arber N,Doki Y,Han E K,et al.Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells[].Cancer Research.1997
-
8Merav Slotky,Maanit Shapira,Ofer Ben-Izhak,et al.The expressionof the ubiquitin ligase subunit Cks1 in human breast cancer[].BreastCancer Research.2005
-
9Bilalovic N,Vranic S,Basic H, et al.Immunohistochemical evaluation of cyclinD1 in breast cancer[].Croatian Medical Journal.2005
-
10M Fu,C Wang,Z Li.Minireview: cyclin D1: normal and abnormal functions[].The Journal of Endocrinology.2004
二级引证文献6
-
1陈绍发.CKS1和CyclinD1在老年肝细胞癌中的表达[J].中国老年学杂志,2013,33(18):4556-4557. 被引量:3
-
2刘换新,白义凤,吴晓霞,郭琳琅.非小细胞肺癌组织PCDH9和cyclin D1表达及其临床意义分析[J].中华肿瘤防治杂志,2014,21(19):1508-1512. 被引量:7
-
3杨影仙,李建民,赵宏光.钙化性乳腺癌数字化X线特征与分子生物学指标表达的相关性研究[J].肿瘤研究与临床,2016,28(8):543-545. 被引量:9
-
4张敏敏,韦薇,刘剑仑,杨华伟,蒋奕.乳腺癌组织LOX蛋白表达与腋窝淋巴结转移相关性分析[J].中华肿瘤防治杂志,2017,24(4):236-241. 被引量:10
-
5高珊珊,伍月红,曹礼慧.石上柏颗粒对肝癌模型小鼠瘤组织中Cyclin D1、CKS表达的影响[J].中医学报,2017,32(10):1828-1831. 被引量:2
-
6高涵,周涛,陈宏月,张春晶,李淑艳.HO-1活性改变对肝癌细胞周期调控因子CKS1和Cyclin D的影响[J].中国老年学杂志,2015,35(3):717-719. 被引量:1
-
1郁宝铭,王敏,许叔祥,李东华,郑民华.大肠癌患者硒与免疫功能关系的研究[J].中华外科杂志,1996,34(1):50-53. 被引量:12
-
2叶胜龙.肝癌的生物治疗[J].肿瘤,1995,15(3):263-266. 被引量:3
-
3叶胜龙.肝癌生物治疗的现状[J].中国临床医学,1999,6(2):101-105. 被引量:1
-
4林言箴,朱正纲.进展期胃癌患者免疫状态的临床研究[J].中华外科杂志,1992,30(12):713-715. 被引量:1
-
5丁彦青.LAK细胞及其肿瘤杀伤机制[J].解放军医学情报,1993,7(3):135-138.
-
6程静新,贺国丽,李庭芳.卵巢恶性肿瘤伴发皮肌炎1例[J].新疆医科大学学报,1997,20(1):42-42.
-
7张建中,朱梅刚,陈意生.恶性淋巴瘤间质组织细胞反应的意义[J].中国肿瘤临床,1990,17(1):52-54.
-
8张惠忠,陆献瑜,赵美卿.肺癌组织中免疫活性细胞和β2微球蛋白的免疫组化研究[J].癌症,1993,12(4):291-294.
-
9Stratigos A.J.,Kapranos N.,Petrakou E.,崔荣.p53基因在非黑素皮肤肿瘤免疫表型的分析及与细胞凋亡和增殖的关联[J].世界核心医学期刊文摘(皮肤病学分册),2005,0(8):28-29.
-
10张士龙,曾甫清,彭世波,汪良.Skp2和P27^(kip1)在膀胱移行上皮细胞癌中的表达及意义[J].临床泌尿外科杂志,2008,23(2):132-134. 被引量:1